Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥179.2bn2023-04-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥63.4bn2023-10-01 → 2023-12-31dCons.Revenue IFRS
Revenue¥230.8bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥175.2bn2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥62.5bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Operating income¥55.0bn2023-04-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income¥20.4bn2023-10-01 → 2023-12-31dCons.Operating profit loss IFRS
Operating income¥58.7bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥22.4bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Profit before tax¥57.3bn2023-04-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥20.0bn2023-10-01 → 2023-12-31dCons.Profit loss before tax IFRS
Profit before tax¥74.3bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥60.2bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥22.2bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥36.6bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥13.2bn2023-10-01 → 2023-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥49.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥39.3bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥15.2bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥38.9bn2023-04-01 → 2023-12-31Cons.Profit loss IFRS
Net income¥13.8bn2023-10-01 → 2023-12-31dCons.Profit loss IFRS
Net income¥41.8bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥15.9bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Total assets¥463.8bnat 2023-12-31Cons.Assets IFRS
Total assets¥400.6bnat 2023-03-31Cons.Assets IFRS
Total assets¥380.7bnat 2022-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥112.7bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥91.1bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥351.1bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥309.5bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥297.4bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥264.0bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥337.1bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥302.6bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥290.7bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥143.1bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥118.3bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥109.8bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥104.3bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥35.6bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥57.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥33.4bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥26.3bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥21.9bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥8.6bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥13.9bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥22.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥20.7bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥53.932023-04-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥19.452023-10-01 → 2023-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥72.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥57.862022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥22.422022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥53.892023-04-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥19.442023-10-01 → 2023-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥72.172022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥57.822022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥22.42022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio72.7%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio75.5%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio76.4%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 107
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥2.6bn
Reconciling Itemsreconcilingrevenue2023-10-01 → 2023-12-31−¥779m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥2.6bn
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2023-12-31−¥779m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥459m
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2023-12-31−¥584m
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue2023-04-01 → 2023-12-31¥12.5bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue2023-10-01 → 2023-12-31¥3.5bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue external2023-04-01 → 2023-12-31¥12.5bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue external2023-10-01 → 2023-12-31¥3.5bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥31m
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue intersegment2023-10-01 → 2023-12-31¥10m
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentsegment profit2023-04-01 → 2023-12-31¥3.9bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentsegment profit2023-10-01 → 2023-12-31¥549m
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue2023-04-01 → 2023-12-31¥20.3bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue2023-10-01 → 2023-12-31¥6.5bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue external2023-04-01 → 2023-12-31¥20.1bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue external2023-10-01 → 2023-12-31¥6.4bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥248m
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2023-10-01 → 2023-12-31¥32m
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentsegment profit2023-04-01 → 2023-12-31¥5.1bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentsegment profit2023-10-01 → 2023-12-31¥1.5bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue2023-04-01 → 2023-12-31¥71.5bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue2023-10-01 → 2023-12-31¥26.0bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue external2023-04-01 → 2023-12-31¥69.3bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue external2023-10-01 → 2023-12-31¥25.3bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥2.2bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue intersegment2023-10-01 → 2023-12-31¥710m
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentsegment profit2023-04-01 → 2023-12-31¥30.4bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentsegment profit2023-10-01 → 2023-12-31¥11.9bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue2023-04-01 → 2023-12-31¥52.1bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue2023-10-01 → 2023-12-31¥19.5bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue external2023-04-01 → 2023-12-31¥52.1bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue external2023-10-01 → 2023-12-31¥19.5bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥15m
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue intersegment2023-10-01 → 2023-12-31¥4m
jpcrp040300-q3r_E05425-000Overseasreportable segmentsegment profit2023-04-01 → 2023-12-31¥12.9bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentsegment profit2023-10-01 → 2023-12-31¥5.6bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue2023-04-01 → 2023-12-31¥23.4bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue2023-10-01 → 2023-12-31¥8.0bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue external2023-04-01 → 2023-12-31¥23.4bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue external2023-10-01 → 2023-12-31¥8.0bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥10m
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue intersegment2023-10-01 → 2023-12-31¥3m
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentsegment profit2023-04-01 → 2023-12-31¥2.6bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentsegment profit2023-10-01 → 2023-12-31¥842m
—segment totalrevenue2023-04-01 → 2023-12-31¥179.8bn
—segment totalrevenue2023-10-01 → 2023-12-31¥63.4bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥177.3bn
—segment totalrevenue external2023-10-01 → 2023-12-31¥62.7bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥2.5bn
—segment totalrevenue intersegment2023-10-01 → 2023-12-31¥759m
—segment totalsegment profit2023-04-01 → 2023-12-31¥54.9bn
—segment totalsegment profit2023-10-01 → 2023-12-31¥20.5bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥3.9bn
Reconciling Itemsreconcilingrevenue2022-10-01 → 2022-12-31−¥1.1bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥3.9bn
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2022-12-31−¥1.1bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.1bn
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2022-12-31−¥418m
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue2022-04-01 → 2022-12-31¥11.5bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue2022-10-01 → 2022-12-31¥3.1bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue external2022-04-01 → 2022-12-31¥10.8bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue external2022-10-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥623m
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥178m
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentsegment profit2022-04-01 → 2022-12-31¥4.2bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentsegment profit2022-10-01 → 2022-12-31¥734m
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue2022-04-01 → 2022-12-31¥20.6bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue2022-10-01 → 2022-12-31¥6.6bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.1bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue external2022-10-01 → 2022-12-31¥6.4bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥521m
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥174m
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentsegment profit2022-04-01 → 2022-12-31¥6.0bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentsegment profit2022-10-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue2022-04-01 → 2022-12-31¥69.8bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue2022-10-01 → 2022-12-31¥27.2bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue external2022-04-01 → 2022-12-31¥67.4bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue external2022-10-01 → 2022-12-31¥26.5bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2.4bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥739m
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentsegment profit2022-04-01 → 2022-12-31¥32.1bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentsegment profit2022-10-01 → 2022-12-31¥13.3bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue2022-04-01 → 2022-12-31¥47.3bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue2022-10-01 → 2022-12-31¥17.1bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue external2022-04-01 → 2022-12-31¥47.2bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue external2022-10-01 → 2022-12-31¥17.1bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥21m
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥17m
jpcrp040300-q3r_E05425-000Overseasreportable segmentsegment profit2022-04-01 → 2022-12-31¥13.9bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentsegment profit2022-10-01 → 2022-12-31¥5.8bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue2022-04-01 → 2022-12-31¥27.5bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue2022-10-01 → 2022-12-31¥8.8bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue external2022-04-01 → 2022-12-31¥27.2bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue external2022-10-01 → 2022-12-31¥8.8bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥304m
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentsegment profit2022-04-01 → 2022-12-31¥3.2bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentsegment profit2022-10-01 → 2022-12-31¥917m
—segment totalrevenue2022-04-01 → 2022-12-31¥176.6bn
—segment totalrevenue2022-10-01 → 2022-12-31¥62.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥172.8bn
—segment totalrevenue external2022-10-01 → 2022-12-31¥61.6bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥3.8bn
—segment totalrevenue intersegment2022-10-01 → 2022-12-31¥1.1bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥59.5bn
—segment totalsegment profit2022-10-01 → 2022-12-31¥22.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 773
ItemContextValueUnit
Assets IFRSPrior1YearInstant400645000000JPY
Assets IFRSCurrentQuarterInstant463840000000JPY
Trade and other payables cl IFRSPrior1YearInstant32864000000JPY
Trade and other payables cl IFRSCurrentQuarterInstant35080000000JPY
Income taxes payable cl IFRSPrior1YearInstant9831000000JPY
Income taxes payable cl IFRSCurrentQuarterInstant5365000000JPY
Provisons for customer loyalty program cl IFRSPrior1YearInstant2219000000JPY
Provisons for customer loyalty program cl IFRSCurrentQuarterInstant2439000000JPY
Other financial liabilities cl IFRSPrior1YearInstant4158000000JPY
Other financial liabilities cl IFRSCurrentQuarterInstant5879000000JPY
Other current liabilities cl IFRSPrior1YearInstant10506000000JPY
Other current liabilities cl IFRSCurrentQuarterInstant9748000000JPY
Total current liabilities IFRSPrior1YearInstant59580000000JPY
Total current liabilities IFRSCurrentQuarterInstant58511000000JPY
Other financial liabilities ncl IFRSPrior1YearInstant9813000000JPY
Other financial liabilities ncl IFRSCurrentQuarterInstant31007000000JPY
Deferred tax liabilities IFRSPrior1YearInstant16805000000JPY
Deferred tax liabilities IFRSCurrentQuarterInstant18151000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant4929000000JPY
Other non current liabilities ncl IFRSCurrentQuarterInstant5044000000JPY
Non current labilities IFRSPrior1YearInstant31547000000JPY
Non current labilities IFRSCurrentQuarterInstant54202000000JPY
Liabilities IFRSPrior1YearInstant91126000000JPY
Liabilities IFRSCurrentQuarterInstant112713000000JPY
Share capital IFRSPrior1YearInstant29192000000JPY
Share capital IFRSCurrentQuarterInstant29298000000JPY
Capital surplus IFRSPrior1YearInstant25081000000JPY
Capital surplus IFRSCurrentQuarterInstant28583000000JPY
Treasury shares IFRSPrior1YearInstant-37000000JPY
Treasury shares IFRSCurrentQuarterInstant-37000000JPY
Other components of equity IFRSPrior1YearInstant17180000000JPY
Other components of equity IFRSCurrentQuarterInstant24331000000JPY
Retained earnings IFRSPrior1YearInstant231214000000JPY
Retained earnings IFRSCurrentQuarterInstant254927000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant302630000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant337102000000JPY
Non controlling interests IFRSPrior1YearInstant6888000000JPY
Non controlling interests IFRSCurrentQuarterInstant14026000000JPY
Equity IFRSPrior1YearInstant309518000000JPY
Equity IFRSCurrentQuarterInstant351128000000JPY
Liabilities and equity IFRSPrior1YearInstant400645000000JPY
Liabilities and equity IFRSCurrentQuarterInstant463840000000JPY
Revenue IFRSPrior1YTDDuration175155000000JPY
Revenue IFRSCurrentYTDDuration179189000000JPY
Cost of sales IFRSPrior1YTDDuration72195000000JPY
Cost of sales IFRSCurrentYTDDuration72322000000JPY
Gross profit IFRSPrior1YTDDuration102959000000JPY
Gross profit IFRSCurrentYTDDuration106868000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration46956000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration54646000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2023-10-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass